Ultralife Corporation
ULBI
$5.68
-$0.09-1.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -10.69% | -4.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.69% | -4.31% | |||
| Cost of Revenue | -8.63% | -2.64% | |||
| Gross Profit | -17.23% | -9.25% | |||
| SG&A Expenses | 3.35% | 1.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.24% | -2.15% | |||
| Operating Income | -114.79% | -32.67% | |||
| Income Before Tax | -257.32% | -54.50% | |||
| Income Tax Expenses | -307.41% | -57.14% | |||
| Earnings from Continuing Operations | -243.33% | -53.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 200.00% | 164.29% | |||
| Net Income | -238.79% | -52.87% | |||
| EBIT | -114.79% | -32.67% | |||
| EBITDA | -72.28% | -22.43% | |||
| EPS Basic | -238.83% | -52.90% | |||
| Normalized Basic EPS | -186.54% | -50.71% | |||
| EPS Diluted | -246.60% | -54.55% | |||
| Normalized Diluted EPS | -186.72% | -50.67% | |||
| Average Basic Shares Outstanding | 0.07% | 0.01% | |||
| Average Diluted Shares Outstanding | -0.06% | -0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||